Faculty of Veterinary Science, The University of Melbourne, Parkville, Victoria, Australia.
Biotechnol Adv. 2013 Dec;31(8):1486-500. doi: 10.1016/j.biotechadv.2013.07.006. Epub 2013 Jul 27.
Angiostrongylus vasorum is a metastrongyloid nematode of dogs and other canids of major clinical importance in many countries. In order to gain first insights into the molecular biology of this worm, we conducted the first large-scale exploration of its transcriptome, and predicted essential molecules linked to metabolic and biological processes as well as host immune responses. We also predicted and prioritized drug targets and drug candidates. Following Illumina sequencing (RNA-seq), 52.3 million sequence reads representing adult A. vasorum were assembled and annotated. The assembly yielded 20,033 contigs, which encoded proteins with 11,505 homologues in Caenorhabditis elegans, and additional 2252 homologues in various other parasitic helminths for which curated data sets were publicly available. Functional annotation was achieved for 11,752 (58.6%) proteins predicted for A. vasorum, including peptidases (4.5%) and peptidase inhibitors (1.6%), protein kinases (1.7%), G protein-coupled receptors (GPCRs) (1.5%) and phosphatases (1.2%). Contigs encoding excretory/secretory and immuno-modulatory proteins represented some of the most highly transcribed molecules, and encoded enzymes that digest haemoglobin were conserved between A. vasorum and other blood-feeding nematodes. Using an essentiality-based approach, drug targets, including neurotransmitter receptors, an important chemosensory ion channel and cysteine proteinase-3 were predicted in A. vasorum, as were associated small molecular inhibitors/activators. Future transcriptomic analyses of all developmental stages of A. vasorum should facilitate deep explorations of the molecular biology of this important parasitic nematode and support the sequencing of its genome. These advances will provide a foundation for exploring immuno-molecular aspects of angiostrongylosis and have the potential to underpin the discovery of new methods of intervention.
血管圆线虫是一种犬和其他犬科动物的寄生线虫,在许多国家具有重要的临床意义。为了初步了解这种蠕虫的分子生物学,我们进行了首次大规模的转录组研究,预测了与代谢和生物学过程以及宿主免疫反应相关的重要分子。我们还预测和确定了药物靶点和候选药物。在 Illumina 测序(RNA-seq)后,共组装和注释了代表成年血管圆线虫的 5230 万条序列。组装得到了 20033 个重叠群,这些重叠群编码的蛋白质在秀丽隐杆线虫中有 11505 个同源物,在其他 2252 个寄生虫中有额外的同源物,这些寄生虫的 curated 数据集可公开获得。预测了 A. vasorum 的 11752 个(58.6%)蛋白质的功能注释,包括肽酶(4.5%)和肽酶抑制剂(1.6%)、蛋白激酶(1.7%)、G 蛋白偶联受体(GPCR)(1.5%)和磷酸酶(1.2%)。编码排泄/分泌和免疫调节蛋白的重叠群代表了转录最活跃的分子之一,并且在血管圆线虫和其他吸血线虫之间保守的消化血红蛋白的酶。使用基于必需性的方法,预测了 A. vasorum 中的药物靶点,包括神经递质受体、一个重要的化学感觉离子通道和半胱氨酸蛋白酶-3,以及相关的小分子抑制剂/激活剂。未来对 A. vasorum 所有发育阶段的转录组分析应该有助于深入探索这种重要的寄生线虫的分子生物学,并支持其基因组测序。这些进展将为探索血管圆线虫的免疫分子方面提供基础,并有可能为新的干预方法的发现提供支持。